CLEC4D and early-onset autosomal dominant Alzheimer disease: The following LPS-stimulated biological processes were activated by TAK 242: Alzheimer disease, renin secretion, nicotinate and nicotinamide metabolism, C-type lectin receptor signaling pathway, PPAR signaling pathway, and non-alcoholic fatty liver disease (NAFLD) (Figure 4F,H).